LYMA
| Private | |
| ISIN | 🆔 |
| Founded 📆 | 2018 |
| Founder 👔 | Lucy Goff |
Area served 🗺️ | |
| Products 📟 | Dietary supplements, laser devices, skincare |
| Members | |
Number of employees | |
| 🌐 Website | lyma |
| 📇 Address | |
| 📞 telephone | |
LYMA is a British health technology company specialising in clinical-grade laser skin devices, a daily supplement and skincare products.
Founded in 2018 by entrepreneur Lucy Goff, the company is headquartered in Marylebone, London.
LYMA operates globally and a significant proportion of its revenue is derived from the United States market.[1]
History
LYMA launched its first product, a supplement, in its founding year.
Goff has spoken openly about how her 2012 battle with septicaemia, following the birth of her first child, profoundly impacted her. It led to her decision to to launch LYMA and shaped the company’s direction.[2] During her recovery, she was introduced to clinical pharmacologist, Professor Paul Clayton, and his expertise was instrumental in creating the supplement.[3]
In 2020, LYMA introduced a hand-held device that uses cold laser therapy technology to help skin heal, repair and rejuvenate.[4]
The company expanded its products with the launch of a skincare line in 2023[5] and released an updated laser device, the LYMA Laser PRO, in 2024.[6]
As of 2026, the company reported revenues of $48 million.[7]
Products
Supplement
The LYMA supplement is a daily nutraceutical formulated with guidance from clinical pharmacologist Professor Paul Clayton.[3] The formula contains 11 patented and peer-reviewed ingredients.[8]
Laser devices
The LYMA Laser, introduced in 2020, is a hand-held device that uses a near-infrared continuous cold laser beam at 808nm.[4] The technology delivers light energy through the skin without causing ablative or thermal effects.[9]
The LYMA Laser PRO, released in 2024, incorporates the same technology and features a larger lens.[6] Both devices are FDA-cleared, clinical grade lasers for use at home.
Skincare
The company introduced a skincare range in 2023 consisting of a serum and a cream.[5] The formulations include a combination of peptides and vitamin derivatives.[10]
Medical and therapeutic applications
LYMA's laser devices are based on photobiomodulation, a form of low-level laser therapy (LLLT) that has been studied for its impact on tissue repair and inflammation.
Low-level laser therapy has been investigated in clinical and experimental settings for applications including wound healing, reduction of inflammation, and support of tissue regeneration. Similar technologies have supported surgical recovery, the healing of chronic wounds, burn injuries and scarring. Modulating cellular activity has been found to have a positive influence.[11]
A 2025 study examining the laser technology used in LYMA devices found changes in gene expression associated with tissue repair and inflammatory pathways. The clinical trials used RNA sequencing to measure gene expression at the molecular level. The results, published in the Aesthetic Surgery Journal 2025, revealed a 103% increase in skin activity in 30 days. The study is the first to reveal evidence of multi-gene longevity activation in human tissue.[12]
Recognition
The LYMA Laser was included in TIME magazine's Best Inventions of 2023.[13]
The company received a King's Award for Enterprise for International Trade in 2023.[14]
LYMA has appeared in listings such as the FT1000 and the Sunday Times 100 Fastest-Growing Private Companies.[15][16]
Reception and criticism
LYMA's products have been the subject of negative commentary regarding pricing and accessibility. Reviews in publications such as The Telegraph and Who What Wear have stated the company's devices and skincare products are expensive.[10][17]
Some reviewers have also criticised the time commitment associated with following the recommended protocols provided for the laser devices.[18]
References
- ↑ "UK beauty brand LYMA's US sales beat forecasts amid tariff woes". The Times.
- ↑ "It's Never Too Late: LYMA founder Lucy Goff on finding purpose at 50". NBC News.
- ↑ 3.0 3.1 "We had skin in the game and laser precision helped us get ahead". The Times.
- ↑ 4.0 4.1 "How the $2,499 LYMA Laser Will Disrupt the Beauty and Wellness Industry". Forbes. 31 December 2021.
- ↑ 5.0 5.1 "LYMA skincare duo: 30,000 people on the waiting list". The Guardian. 27 June 2023.
- ↑ 6.0 6.1 "LYMA Laser PRO". Financial Times.
- ↑ "LYMA sales soar following US expansion". The Industry Beauty.
- ↑ "LYMA Supplement Review: A Doctor's Take". Hers.
- ↑ "Is the LYMA Laser Worth It? Here's My Honest Review". Allure. 19 April 2024.
- ↑ 10.0 10.1 "LYMA face cream and serum review". The Telegraph.
- ↑ Taha, Nadia; Daoud, Hasan; Malik, Tahira; Shettysowkoor, Jeevith; Rahman, Shafiq (October 2024). "The Effects of Low-Level Laser Therapy on Wound Healing and Pain Management in Skin Wounds: A Systematic Review and Meta-Analysis". Cureus. 16 (10): e72542. doi:10.7759/cureus.72542. ISSN 2168-8184. PMC 11602420 Check
|pmc=value (help). PMID 39610644 Check|pmid=value (help). - ↑ Glass, G. E.; Mérai, A.; Molnár, S.; Clayton, P. (2025). "Clinical evaluation of a proprietary near-infrared laser for wound healing and inflammation reduction". Journal of Wound Care. 7: ojaf009. doi:10.1093/asjof/ojaf009. PMC 11975535 Check
|pmc=value (help). PMID 40201332 Check|pmid=value (help). - ↑ "LYMA Laser — Best Inventions 2023". TIME.
- ↑ "King's Awards for Enterprise 2023 — International Trade winners".
- ↑ "FT1000: Europe's Fastest Growing Companies 2024". Financial Times. March 2024.
- ↑ "The Sunday Times reveals Britain's 100 fastest-growing private companies". The Sunday Times.
- ↑ "I Tested the Lyma Laser Pro for 49 Days — My Honest Review". Who What Wear. 17 May 2025.
- ↑ "Lyma Laser Review (2026)—Is It Worth The Hefty Price Tag? | mindbodygreen". www.mindbodygreen.com. 27 August 2023. Retrieved 2026-05-03.
External links
This article "LYMA (2)" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:LYMA (2). Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
